Treatment of neurodegenerative disease through intracranial delivery of siRNA

Details for Australian Patent Application No. 2005248389 (hide)

Owner Medtronic, Inc.

Inventors Kaemmerer, William F.

Agent FB Rice

Pub. Number AU-A-2005248389

PCT Pub. Number WO2005/116212

Priority 10/852,997 25.05.04 US

Filing date 24 May 2005

Wipo publication date 8 December 2005

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

A61K 31/713 (2006.01) - Double-stranded nucleic acids or oligonucleotides

A61M 25/00 (2006.01) Catheters

A61M 37/00 (2006.01) Other apparatus for introducing media into the body

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

23 November 2006 PCT application entered the National Phase

  PCT publication WO2005/116212 Priority application(s): WO2005/116212

6 August 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005248392-Site specific incorporation of heavy atom-containing unnatural amino acids into proteins for crystal structure determination

2005248377-Influenza hemagglutinin and neuraminidase variants